about
PET Imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in Progressive Multifocal LeukoencephalopathyBinding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region.Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report.Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading.Plasma Glucose Levels Affect Cerebral 18F-FDG Distribution in Cognitively Normal Subjects With Diabetes.Changes in brain amyloid-β accumulation after donepezil administration.Comparison of imaging using 11C-ITMM and 18F-FDG for the detection of cerebellar ataxia.Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia.Effects of glucose, insulin, and insulin resistance on cerebral 18F-FDG distribution in cognitively normal older subjects.Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A (11)C-ITMM PET study.Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment.Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease.Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease.Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effect.Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.Regional analysis of striatal and cortical amyloid deposition in patients with Alzheimer's disease.Potential Use of 18F-THK5351 PET to Identify Wallerian Degeneration of the Pyramidal Tract Caused by Cerebral Infarction.Microglial Activation on 11C-CB184 PET in a Patient With Cerebellar Ataxia Associated With HIV Infection.Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading.Altered functional connectivity of the default mode network by glucose loading in young, healthy participants.Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using C-ITMM positron emission tomographyOccupancy of adenosine A2A receptors by istradefylline in patients with Parkinson's disease using 11C-preladenant PETBrain 18F-FDG distribution: which region is most affected by increased plasma glucose levels?Longitudinal effects of aging on 18F-FDG distribution in cognitively normal elderly individuals
P50
Q32182145-F2CD0185-5701-4F10-B9F6-256C5B75ED90Q33847160-367D696E-C02F-471C-A85B-B4FB12F6B200Q33921691-6870E7EE-2CB0-4CB3-98B3-AB19AA45F2F5Q35792439-4F3CEC2E-099E-4F6B-BEA0-3BC5F513A7E2Q35925410-D06F7895-7335-4889-85FE-7C4E42FB97DDQ40011459-7DCFE837-6A0D-4062-BAF4-E91123A0E36EQ40070206-5F22D560-F331-4C7F-9569-68D85AB7C2B6Q40287643-DEAFA7F5-A636-4C1C-97B2-18A697646CA8Q40584019-B43D9372-A53C-4C32-B973-607BFD115CA0Q41035428-51865362-2960-457C-9228-09CA1410AB67Q41175564-5C64D8FA-38C0-47B4-A929-2C07654C8107Q42212223-B1E58981-74E6-4D98-BD8B-9B7D4FEEA332Q43225553-B6EA8E28-4001-4BF9-B350-0A5630A8C4B3Q43228555-3D10132E-24C8-4B4D-8886-F4C4879F8478Q45922533-CA026ED9-0AC9-45C0-9FD2-1A78C84DC0F0Q46926161-3C1BC3C8-19C2-498E-A7A2-F2D1899FDF24Q48383370-692807D2-0DCD-44F9-8D0A-88078D3FB86FQ48741820-460EC12A-4655-44F6-8128-84B229106E65Q50095167-1A67F796-24A1-4909-88B2-279D41F3A795Q50137627-9B9B88FA-DDC6-4B6E-9FAE-A6E4FFC40275Q51286113-7D9EE688-5252-4FA7-9696-48BD3F8C6177Q55398487-7E31527A-3EA8-4493-961A-A568EB13CF3BQ64084664-9580ED5B-A6F2-47FA-AEEF-6D50B7D7FD06Q64859272-067D7639-2645-46C4-88CC-91D0E75DBD43Q64942511-47B06DA5-B9EF-425B-B211-E0E464444750Q90698745-49A09365-3D12-49C7-AC65-CE0481BDBD94
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kenji Ishibashi
@ast
Kenji Ishibashi
@en
Kenji Ishibashi
@es
Kenji Ishibashi
@nl
Kenji Ishibashi
@sl
type
label
Kenji Ishibashi
@ast
Kenji Ishibashi
@en
Kenji Ishibashi
@es
Kenji Ishibashi
@nl
Kenji Ishibashi
@sl
prefLabel
Kenji Ishibashi
@ast
Kenji Ishibashi
@en
Kenji Ishibashi
@es
Kenji Ishibashi
@nl
Kenji Ishibashi
@sl
P106
P31
P496
0000-0002-4590-7146